Clinical Diagnosis and Analysis of Cancers
A special issue of Genes (ISSN 2073-4425). This special issue belongs to the section "Human Genomics and Genetic Diseases".
Deadline for manuscript submissions: closed (25 August 2025) | Viewed by 700
Special Issue Editor
Special Issue Information
Dear Colleagues,
Technological advances in the evaluation and diagnosis of cancer over the most recent decade have made it possible to improve the treatment of patients with oncological diseases. By exploring molecular and epigenetic alterations, proteomic features and signatures, and functional pathways, we seek to enhance our understanding of cancer pathophysiology.
Most recently, the availability of computational approaches, machine learning, and artificial intelligence has revolutionized our understanding of complex molecular system, allowing the identification of novel biomarkers and therapeutic approaches.
This Special Issue, titled “Clinical Diagnosis and Analysis of Cancers”, aims to collect high-quality articles on advances in oncological research with a focus on molecular, omics, and technological approaches.
The topics of interest include, but are not limited to, the following:
- Molecular and cellular genetics of cancer;
- Proteogenomic and bioinformatic approaches to understanding cancer;
- New genetic editing techniques and their clinical applications in cancer research;
- New pre-clinical and clinical approaches to cancer diagnosis and evaluation
- Machine learning and artificial intelligence analyses;
- Understanding of genetics and molecular biomarkers of rare cancers.
Dr. Elisa De Paolis
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer genetics
- cancer proteomics
- cancer diagnosis
- cancer treatments
- next-generation sequencing
- genetic editing
- machine learning
- artificial intelligence
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
